Global Custom Market Research Reports Provider Company

phone

Neuren Pharmaceuticals Ltd (NEU) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: Australia
Summary

Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company offers pipeline products such as trofinetide and NNZ-2591. Its trofinetide has a pharmacokinetic profile, which is suitable for intravenous infusion and oral delivery. Neuren Pharma undertakes clincal trials for several drugs. The companys drugs are also used in neurodevelopmental disorders such as angelman syndrome and idiopathic autism, or neurodegenerative disorders such as Parkinsons disease and multiple sclerosis. Neuren Pharma is headquartered in Melbourne, Victoria, Australia.

Neuren Pharmaceuticals Ltd Key Recent Developments

Aug 24,2017: Neuren reports 2017 half-year results
Jun 29,2017: Neuren Announces 2017 Annual Shareholders Meeting Chairmans Address
Oct 31,2016: Neuren Pharmaceuticals: Appendix 4C Quarterly Report
Jun 30,2016: Neuren Pharmaceuticals: Appendix 4D Half-Year Financial Report
Feb 25,2016: Neuren reports 2015 full-year financial results

This comprehensive SWOT profile of Neuren Pharmaceuticals Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neuren Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Neuren Pharmaceuticals Ltd - Key Information

Neuren Pharmaceuticals Ltd - Overview

Neuren Pharmaceuticals Ltd - Key Employees

Neuren Pharmaceuticals Ltd - Key Employee Biographies

Neuren Pharmaceuticals Ltd - Key Operational Heads

Neuren Pharmaceuticals Ltd - Major Products and Services

Neuren Pharmaceuticals Ltd - History

Neuren Pharmaceuticals Ltd - Company Statement

Neuren Pharmaceuticals Ltd - Locations And Subsidiaries

Neuren Pharmaceuticals Ltd - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Neuren Pharmaceuticals Ltd - Business Description

Neuren Pharmaceuticals Ltd - Corporate Strategy

Neuren Pharmaceuticals Ltd - SWOT Analysis

SWOT Analysis - Overview

Neuren Pharmaceuticals Ltd - Strengths

Neuren Pharmaceuticals Ltd - Weaknesses

Neuren Pharmaceuticals Ltd - Opportunities

Neuren Pharmaceuticals Ltd - Threats

Neuren Pharmaceuticals Ltd - Key Competitors



Section 3 - Company Financial Performance Charts



Neuren Pharmaceuticals Ltd - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Neuren Pharmaceuticals Ltd, Key Information

Neuren Pharmaceuticals Ltd, Key Ratios

Neuren Pharmaceuticals Ltd, Share Data

Neuren Pharmaceuticals Ltd, Major Products and Services

Neuren Pharmaceuticals Ltd, History

Neuren Pharmaceuticals Ltd, Key Employees

Neuren Pharmaceuticals Ltd, Key Employee Biographies

Neuren Pharmaceuticals Ltd, Key Operational Heads

Neuren Pharmaceuticals Ltd, Other Locations

Neuren Pharmaceuticals Ltd, Subsidiaries

Neuren Pharmaceuticals Ltd, Key Manufacturing facilities

Neuren Pharmaceuticals Ltd, Key Competitors

Neuren Pharmaceuticals Ltd, SWOT Analysis

Neuren Pharmaceuticals Ltd, Ratios based on current share price

Neuren Pharmaceuticals Ltd, Annual Ratios

Neuren Pharmaceuticals Ltd, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Neuren Pharmaceuticals Ltd, Performance Chart

Neuren Pharmaceuticals Ltd, Ratio Charts

Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company offers pipeline products such as trofinetide and NNZ-2591. Its

View Report

Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company offers pipeline products such as trofinetide and NNZ-2591. Its

View Report

Neuren Pharmaceuticals Limited (NEU) - Financial and Strategic SWOT Analysis Review market research report at USD 300 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports